Reporter brief
Randomized Controlled Trial of Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome
What happened
Trial registry update: COMPLETED. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- No findings are reported in the available material, so no causal or preventive effects can be evaluated.
- The sample size and effect sizes are not provided, preventing assessment of statistical power or clinical significance.
- As an abstract-only source, this does not present the full study protocol, outcomes, or any completed analyses.
Study design and sample
Rct; Human.
Men and women with Metabolic syndrome (MetS)
- Design
- Rct
- Sample
- —
- Journal
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Published
- Sep 28, 2021
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Metformin timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.